Protagonist Therapeutics, Inc.

NASDAQ:PTGX

41.49 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014
Revenue 6026.58127.35728.6280.23130.92520.063000
Cost of Revenue 01.0322.77500000.3170.2470
Gross Profit 6025.54924.58228.6280.23130.92520.063-0.317-0.2470
Gross Profit Ratio 10.9610.8991111000
Reseach & Development Expenses 120.161126.215126.00674.50665.00359.49746.18125.70511.8317.459
General & Administrative Expenses 33.49131.73927.19618.63815.74913.69711.7796.9612.9631.86
Selling & Marketing Expenses 0000000000
SG&A 33.49131.73927.19618.63815.74913.69711.7796.9612.9631.86
Other Expenses 0-0.08-0.149-0.046-0.00100-0.03400
Operating Expenses 153.652157.954153.20293.14480.75273.19457.9632.66614.7949.319
Operating Income -93.652-131.373-125.845-64.516-80.521-42.269-37.897-32.666-14.794-9.319
Operating Income Ratio -1.561-4.942-4.6-2.254-348.576-1.367-1.889000
Total Other Income Expenses Net 14.6973.980.294-0.3292.6432.5460.94-4.511-0.064-1.753
Income Before Tax -78.955-127.393-125.551-64.845-77.878-39.723-36.957-37.177-14.858-11.072
Income Before Tax Ratio -1.316-4.793-4.589-2.265-337.134-1.284-1.842000
Income Tax Expense 0-3.98-2.9241.305-0.691-0.799-0.4064.160.0641.753
Net Income -78.955-123.413-122.627-66.15-77.187-38.924-36.957-37.177-14.858-11.072
Net Income Ratio -1.316-4.643-4.482-2.311-334.143-1.259-1.842000
EPS -1.39-2.52-2.65-1.92-2.98-1.74-2.09-5.72-2.52-1.88
EPS Diluted -1.39-2.52-2.65-1.92-2.98-1.74-2.09-5.72-2.52-1.88
EBITDA -90.34-131.373-123.07-63.662-78.306-39.196-36.551-32.349-14.547-9.061
EBITDA Ratio -1.506-4.942-4.589-2.224-336.403-1.367-1.889000